Last Posted: Oct 04, 2018
- Burden of familial heterozygous hypercholesterolemia in Uzbekistan: Time is muscle.
Shek Aleksandr et al. Atherosclerosis 2018 Oct 277524-529 - Clinical and genetic characteristics of familial hypercholesterolemia patients with type 2 diabetes.
Sun D et al. Journal of endocrinological investigation 2018 Oct - Clinical utility of the polygenic LDL-C SNP score in familial hypercholesterolemia.
Futema Marta et al. Atherosclerosis 2018 Oct 277457-463 - DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores.
Miserez A R et al. Atherosclerosis 2018 Oct 277282-288 - Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study.
Casula Manuela et al. Atherosclerosis 2018 Oct 277413-418 - Familial hypercholesterolemia screening program in Bosnia and Herzegovina and cardiovascular morbidity.
Pojskic Lamija et al. Atherosclerosis 2018 Oct 277278-281 - Familial hypercholesterolemia treatments: Guidelines and new therapies.
Raal Frederick J et al. Atherosclerosis 2018 Oct 277483-492 - Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil.
Souto Ana Cristina et al. Atherosclerosis 2018 Oct 277464-469 - Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in Taiwan.
Hsiung Yun-Chieh et al. Atherosclerosis 2018 Oct 277440-447 - Latvian registry of familial hypercholesterolemia: The first report of three-year results.
Latkovskis Gustavs et al. Atherosclerosis 2018 Oct 277347-354
No hay comentarios:
Publicar un comentario